Actively Recruiting
Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)
Led by Oslo University Hospital · Updated on 2024-12-31
600
Participants Needed
1
Research Sites
296 weeks
Total Duration
On this page
Sponsors
O
Oslo University Hospital
Lead Sponsor
U
University Hospital, Akershus
Collaborating Sponsor
AI-Summary
What this Trial Is About
Extended pelvic lymph node dissection (ePLND) is considered the gold standard for nodal staging in men with prostate cancer (PCa). The aim of this project is to determine if preoperative prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomograpy (CT) can safely replace ePLND as a staging method in PCa patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP).
CONDITIONS
Official Title
Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy-proven adenocarcinoma of the prostate
- Indication for ePLND combined with RALP including high-risk group (EAU) or MRI showing extra prostatic extension (Likert scale 4)
- ISUP Grade Group 3 with at least one unfavorable risk factor: clinical stage T2b-c, 50% or more positive biopsy cores, or PSA 10-20
- Selected cN1 patients planned for surgery
- 18 years of age or older
- Written informed consent provided
- No known allergies to PSMA tracer
You will not qualify if you...
- History of previously treated active prostate cancer
- Previous cancers (except basal cell skin carcinoma) not recurrence-free for at least 5 years
- Unable or unwilling to undergo PSMA PET/CT, ePLND, or RALP
- Presence of distant metastasis (cM1) on MRI imaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hospital
Oslo, Norway, 4950
Actively Recruiting
Research Team
V
Viktor Berge, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here